These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 30062791)

  • 1. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
    Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
    Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C as a marker of acute kidney injury in the emergency department.
    Soto K; Coelho S; Rodrigues B; Martins H; Frade F; Lopes S; Cunha L; Papoila AL; Devarajan P
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1745-54. PubMed ID: 20576828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of the biomarkers at the time of nephrology consultation might predict the prognosis of acute kidney injury in hospitalized patients.
    Renhua L; Miaolin C; Junlin W; Qingwei W; Xiaoping X; Huili D; Weiming Z; Zhaohui N; Jiaqi Q; Yan Y
    Blood Purif; 2014; 38(2):89-95. PubMed ID: 25342236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.
    Jo SK; Yang J; Hwang SM; Lee MS; Park SH
    Sci Rep; 2019 Oct; 9(1):14508. PubMed ID: 31601879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
    Ho J; Tangri N; Komenda P; Kaushal A; Sood M; Brar R; Gill K; Walker S; MacDonald K; Hiebert BM; Arora RC; Rigatto C
    Am J Kidney Dis; 2015 Dec; 66(6):993-1005. PubMed ID: 26253993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of serum cystatin C for acute kidney injury in patients with liver cirrhosis].
    Cai JJ; Zhou J; Han T; Zhang YL; Liu HP; Fu YC
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):360-364. PubMed ID: 28763843
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.
    Allegretti AS; Parada XV; Endres P; Zhao S; Krinsky S; St Hillien SA; Kalim S; Nigwekar SU; Flood JG; Nixon A; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Regner KR; Belcher JM; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT;
    Clin Transl Gastroenterol; 2021 May; 12(5):e00359. PubMed ID: 33979307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis.
    Yap DY; Seto WK; Fung J; Chok SH; Chan SC; Chan GC; Yuen MF; Chan TM
    Dig Liver Dis; 2017 Feb; 49(2):202-206. PubMed ID: 27876501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
    Benzer M; Alpay H; Baykan Ö; Erdem A; Demir IH
    Ren Fail; 2016; 38(1):27-34. PubMed ID: 26584598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study.
    Kim TH; Seo YS; Kang SH; Kim MY; Kim SG; Lee HY; Lee JH; Lee YS; Kim JH; Jeong SW; Jang JY; Suk KT; Jung YK; An H; Yim HJ; Kim YS; Um SH;
    Liver Int; 2020 Dec; 40(12):3083-3092. PubMed ID: 32750739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU.
    Xiong J; Pu L; Xiong H; Xiang P; Zhang M; Liu J; Li A
    Scand J Gastroenterol; 2018 Dec; 53(12):1590-1596. PubMed ID: 30621473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge about biomarkers of acute kidney injury in liver cirrhosis.
    Lee HA; Seo YS
    Clin Mol Hepatol; 2022 Jan; 28(1):31-46. PubMed ID: 34333958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.
    Unal S; Kotan C; Delibas A; Oztas Y
    Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Urinary
    Yoo JJ; Kwon JH; Kim YS; Nam SW; Park JW; Kim HY; Kim CW; Shin SK; Chon YE; Jang ES; Jeong SH; Lee JW; Song DS; Yang JM; Lee SW; Lee HL; Jung YK; Yim HJ; Lee B; Kim SG; Kim JH
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Application of Kidney Biomarkers in Cirrhosis.
    Allegretti AS; Solà E; Ginès P
    Am J Kidney Dis; 2020 Nov; 76(5):710-719. PubMed ID: 32622560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients.
    Lee JH; Yoon EL; Park SE; Park JY; Choi JM; Jeon TJ; Shin WC; Choi WC
    Korean J Gastroenterol; 2019 Oct; 74(4):212-218. PubMed ID: 31650797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Kidney Injury in Liver Disease: Role of Biomarkers.
    Belcher JM
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):368-75. PubMed ID: 26311598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis.
    Lei L; Li LP; Zeng Z; Mu JX; Yang X; Zhou C; Wang ZL; Zhang H
    Sci Rep; 2018 May; 8(1):7962. PubMed ID: 29784944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.